Allspring Global Investments Holdings, LLC Xencor Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Xencor Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 80 shares of XNCR stock, worth $1,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Holding current value
$1,845
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$15.7 - $21.65 $1,256 - $1,732
80 New
80 $1,000
Q3 2023

Oct 27, 2023
BUY
$20.08 - $25.39 $34,939 - $44,178
1,740 New
1,740 $35,000
Q2 2023

Jul 18, 2023
SELL
$24.77 - $29.9 $756,327 - $912,966
-30,534 Reduced 89.9%
3,432 $85,000
Q1 2023

Apr 13, 2023
BUY
$25.95 - $36.95 $742,818 - $1.06 Million
28,625 Added 535.95%
33,966 $947,000
Q4 2022

Jan 23, 2023
SELL
$24.79 - $30.86 $29,871 - $37,186
-1,205 Reduced 18.41%
5,341 $139 Million
Q3 2022

Oct 26, 2022
BUY
$24.62 - $32.44 $62,436 - $82,267
2,536 Added 63.24%
6,546 $170,000
Q2 2022

Jul 25, 2022
SELL
$19.74 - $29.01 $853,577 - $1.25 Million
-43,241 Reduced 91.51%
4,010 $109,000
Q1 2022

May 02, 2022
SELL
$26.68 - $41.63 $66,619 - $103,950
-2,497 Reduced 5.02%
47,251 $1.26 Million
Q4 2021

Jan 28, 2022
BUY
$33.67 - $43.44 $1.68 Million - $2.16 Million
49,748 New
49,748 $2 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email